Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL CholesterolZeljko Reiner, Garen Manvelian, Robert Pordy et al.|Journal of the American College of Cardiology|2021Cited by 143
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMESPhilippe Gabríel Steg, Nikolaus Marx, Michael Szarek et al.|Circulation|2025Cited by 23